Seal Shield Acquires Vioguard, Fortifying Arsenal Against Superbugs

JACKSONVILLE, FL – March 05, 2026 – In a significant move to consolidate its leadership in the infection control market, Seal Shield LLC today announced the strategic asset acquisition of Vioguard, a company renowned for its pioneering ultraviolet (UV-C) sanitization technology. The deal brings Vioguard's FDA-cleared keyboard sanitizing system under the umbrella of Seal Shield, a global leader in hygienic medical-grade devices, signaling an intensified focus on combating healthcare-associated infections (HAIs) and enhancing hygiene standards across multiple industries.

This acquisition integrates Vioguard's unique intellectual property and product line into Seal Shield's already robust portfolio, which includes waterproof peripherals, chemical-resistant screen protectors, and other advanced UV-C sanitization systems. The move is poised to create one of the most comprehensive offerings for device hygiene available, addressing a critical vulnerability in modern healthcare and professional environments: the contaminated surfaces of shared electronics.

A Strategic Play in a Booming Market

The acquisition is more than just an expansion of a product catalog; it is a calculated maneuver in the rapidly growing global infection control market. With the UV-C disinfection sector alone projected to soar to nearly $40 billion by 2035, companies are racing to innovate and capture market share. This growth is fueled by a heightened global awareness of pathogen transmission and the persistent challenge of HAIs, which continue to plague healthcare systems worldwide.

For Seal Shield, this is the latest in a series of strategic acquisitions designed to bolster its market position. The company previously acquired CleanSlate UV in June 2023, integrating its rapid device sanitization technology. The addition of Vioguard and its specialized, FDA-cleared keyboard system demonstrates a clear strategy: to assemble a complete, multi-faceted arsenal of hygiene solutions. By acquiring companies with proven, specialized technologies, Seal Shield is positioning itself as a one-stop-shop for organizations seeking to implement comprehensive infection prevention protocols. The deal, whose financial terms were not disclosed, involved Imagen Capital Partners, a majority stockholder in Vioguard's former merged entity UV360, as a seller.

The Power of FDA Clearance

A key jewel in the Vioguard acquisition is its status as the developer of the first FDA-cleared UV-C system for keyboard surface sanitation. In a market flooded with disinfection gadgets making a wide range of claims, this regulatory milestone provides a powerful differentiator. Vioguard’s technology received a 510(k) clearance from the U.S. Food and Drug Administration, classifying it as a Class II medical device. This clearance is not a simple approval; it signifies that the device has been demonstrated to be "substantially equivalent" to a legally marketed predicate device in terms of safety and effectiveness, meeting stringent performance, labeling, and validation requirements.

This FDA clearance provides healthcare administrators and infection control specialists with a level of assurance that is crucial when making procurement decisions. The technology's effectiveness is not just a marketing claim but is supported by independent research. Studies conducted by researchers from Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center concluded that Vioguard's automated sanitization could help reduce the spread of dangerous pathogens like C. diff, influenza strains, and even Ebola on shared computer keyboards. This validated efficacy makes the technology a critical tool in high-stakes environments where cleanliness can directly impact patient outcomes.

Building a Comprehensive Sanitization Ecosystem

Seal Shield's existing UV-C product line, featuring the ElectroClave™ and CleanSlate™ systems, already addresses significant needs in device hygiene. The ElectroClave provides 360-degree UV-C disinfection for multiple mobile devices, coupled with a smart management system for tracking and compliance. CleanSlate offers a rapid, 20-second sanitization cycle ideal for point-of-care use on phones, tablets, and other small items. The integration of Vioguard's technology creates powerful synergy, filling a specific and critical gap.

Keyboards are notoriously difficult to clean and are one of the highest-touch surfaces in any facility, often harboring more bacteria than a toilet seat. Vioguard’s self-sanitizing keyboard addresses this problem directly and automatically. This specialized solution complements Seal Shield's broader device sanitizers perfectly. An organization can now use CleanSlate for personal devices at entry points, ElectroClave for managing and sanitizing a fleet of shared tablets, and rely on Vioguard's technology to ensure every workstation keyboard is consistently and effectively disinfected.

"We are excited to welcome Vioguard to the Seal Shield family," said Brad Whitchurch, CEO of Seal Shield, in a statement. "Vioguard has been a pioneer in developing UV-C technologies specifically designed to address contamination risks from shared workstations and devices. By combining their innovations with Seal Shield's expertise in hygienic device design, we are expanding our ability to provide organizations with advanced hygienic solutions that help create cleaner environments."

Beyond the Hospital Walls

While the immediate focus of this technology is on healthcare, the implications extend far beyond hospital corridors. The pandemic fundamentally shifted public and corporate perceptions of hygiene, creating demand for medical-grade sanitization in everyday life. Shared workstations in corporate offices, library computers in universities, check-in kiosks at airports, and point-of-sale systems in retail are all potential vectors for disease transmission.

The integration of Vioguard's technology into Seal Shield’s portfolio positions the company to meet this expanding demand. The same principles of reducing pathogen load on high-touch surfaces to protect vulnerable patients are now being applied to protect employees, customers, and students. As organizations increasingly adopt more stringent hygiene protocols as a standard operating procedure, the market for proven, automated, and easy-to-use sanitization solutions is set to expand significantly.

To mark the integration, Seal Shield will be showcasing the Vioguard UV sanitization system at the upcoming HiMSS26 tradeshow in Las Vegas from March 10-12. The technology will be featured at a dedicated UV product pavilion within Seal Shield's booth, allowing industry professionals to see firsthand how this newly expanded portfolio of solutions works together to create a new standard of clean.